P

Inventor

KARKI RAJESH

US16 patents
⚠️ This page may combine multiple inventors who share the name “KARKI RAJESH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVARTIS AG

11 patents
US10968235B2Apr 6, 2021

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

NOVARTIS AG3 citations83
US10336774B2Jul 2, 2019

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

NOVARTIS AG7 citations83
US10301278B2May 28, 2019

1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2

NOVARTIS AG8 citations83
US10287266B2May 14, 2019

Compounds and compositions for inhibiting the activity of SHP2

NOVARTIS AG8 citations82
US10934285B2Mar 2, 2021

Compounds and compositions for inhibiting the activity of SHP2

NOVARTIS AG5 citations72
US12209098B2Jan 28, 2025

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

NOVARTIS AG0 citations62
US11952386B2Apr 9, 2024

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

NOVARTIS AG0 citations62
US11905283B2Feb 20, 2024

Compounds and compositions for inhibiting the activity of SHP2

NOVARTIS AG0 citations62
US11401259B2Aug 2, 2022

1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2

NOVARTIS AG0 citations60
US10377770B2Aug 13, 2019

Tricyclic compounds and compositions as kinase inhibitors

NOVARTIS AG1 citations59
US12129246B1Oct 29, 2024

Hydroquinazoline derivatives for the treatment of a disease or disorder

NOVARTIS AG0 citations45

CHEN CHRISTINE HIU TUNG

3 patents

DAI MIAO

1 patent

CHEN ZHUOLIANG

1 patent